TopBuild Corp
F:28T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TopBuild Corp
F:28T
|
US |
|
Clariane SE
OTC:KRNMF
|
FR |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
F
|
F5 Inc
XMUN:FFV
|
US |
|
F
|
Fortune Brands Home & Security Inc
F:2FB
|
US |
|
C
|
Comfort Systems USA Inc
F:9CF
|
US |
Wall St Price Targets
28T Price Targets Summary
TopBuild Corp
According to Wall Street analysts, the average 1-year price target for 28T is 464.24 EUR with a low forecast of 415.76 EUR and a high forecast of 524.06 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 28T's stock price target?
Price Target
464.24
EUR
According to Wall Street analysts, the average 1-year price target for 28T is 464.24 EUR with a low forecast of 415.76 EUR and a high forecast of 524.06 EUR.
What is the Revenue forecast for TopBuild Corp?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for TopBuild Corp?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 2 years is 7%.
What is the Operating Income forecast for TopBuild Corp?
Projected CAGR
6%
Over the last 12 years, the compound annual growth rate for Operating Income has been 35%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for TopBuild Corp?
Projected CAGR
8%
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 42%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for TopBuild Corp?
Projected CAGR
8%
The compound annual growth rate for Net Income over the next 3 years is 8%.
